Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04079439
Other study ID # HNF1353-17
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date January 1, 2022

Study information

Verified date June 2021
Source University Hospital of North Norway
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this project is to enhance physical activity in youths and adults with intellectual disabilities (IDs) by developing and testing a tailored e-heath support for motivation and participation in physical activity.


Description:

Individuals with intellectual disability (ID) have lower levels of physical activity and greater barriers for participation in fitness activities, compared to the general population. As increased physical activity has positive effects on cardiovascular and psychosocial health, identifying effective interventions for use in everyday settings is exceedingly important. E-health like motion sensor games (exergames) and smartphone reminders for physical activity have been explored and found to be promising in people with ID. The purpose of this study is to examine the effectiveness of an individually tailored PA programme with motivational mobile e-health support on everyday level of PA in youths and adults with ID. The PA-IDE trial uses a prospective randomized controlled design. In total, 60 participants with a sedentary lifestyle or low physical activity level will be included, aging from 16-60 years old. The intervention consists of a tailored e-health support intervention, using smartphones or tablets to create structure and predictability of physical activities. The intervention emphasizes the communicative abilities of individual participants and use rewards and give feedback of progress to motivate individuals to increase participation in physical activity. Participants will be allocated to groups consisting of 30 participants who receive either the e-health intervention or standard care (control). All participants will be assessed at baseline, 3-, and 6 months. Participants in the intervention group, close relatives or care staff will be invited to participate in a goal-setting meeting about physical activity in the intervention period, where the Goal Attainment Scaling (GAS) will be used. Primary outcome will be physical activity level measured as steps per day with commercial wrist-worn accelerometers. Secondary outcome measures include minutes of moderate activity, energy expenditure, social support for physical activity, self-efficacy in a PA setting, behaviour problems, and goal attainment. The investigators expect that the new intervention will perform better than standard care in terms of improved physical activity, mastery, and social support for activities. Technology offers new opportunities to influence healthy behaviours. The trial results will determine the effectiveness and sustainability of a tailored e-health support intervention to increase physical activity among youths and adults with ID.


Recruitment information / eligibility

Status Terminated
Enrollment 60
Est. completion date January 1, 2022
Est. primary completion date May 1, 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years to 60 Years
Eligibility Inclusion Criteria: - Intellectual disability - Age 15-60 years - Low physical activity - Sedentary lifestyle Exclusion Criteria: - Medical contradictions for participation - High levels of physical activity

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical activity with tailored e-health support
The planned e-health intervention will contain several elements: A motivating smartphone app registers indoor- and outdoor activity as well as activity from the use of an ergometer-bike. For recording of outdoor activity commercial wrist-born accelerometers will be used. The app-solution will be motivating and result in a reward after a predefined level of activity.

Locations

Country Name City State
Norway University Hospital of North Norway Tromsø

Sponsors (2)

Lead Sponsor Collaborator
University Hospital of North Norway The Royal Norwegian Ministry of Health

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Steps per day The primary outcome is physical activity, objectively assessed by steps per day measured with an accelerometer. This will objectively assess physical activity and sedentary time. Change in steps per day is being assessed at baseline, after three months of intervention and after 6 months of intervention. Baseline, 3 months and 6 months
Secondary Physical activity The International Physical Activity Questionnaire - Short Form, adapted to measure PA using proxy respondents (IPAQ-SF) will be used. The IPAQ-SF is a 7-item questionnaire that assesses PA the last seven days at four intensity levels: 1) vigorous-intensity activity such as aerobics, 2) moderate-intensity activity such as leisure cycling, 3) walking, and 4) sitting. Baseline, 3 months and 6 months
Secondary Blood pressure The blood pressure will be measured in units of millimeters of mercury (mmHg) using Welsh-Allyn device. Both systolic blood pressure and diastolic blood pressure will be measured. Baseline, 3 months and 6 months
Secondary Waist Circumference Waist circumference will be measured in cm. Measurements will be done 1 cm above the navel. Baseline, 3 months and 6 months
Secondary Body Mass Index (BMI) Height will be measured with a stadiometer (Seca) in meters, with the participant wearing no shoes. Weight measured with an analog, floor scale (Seca) in kilograms, with participants wearing no shoes or outdoors jacket/gears. For participants in wheelchair or with difficulty standing on a small plate a wheelchair weight (Seca) will be used. Weight and height will be combined to report BMI in kg/m^2. Baseline, 3 months and 6 months
Secondary Physical functioning The Short Physical Performance Battery (SPPB) will used to assess physical functioning. The SPPB is a screening test designed to assess physical performance and predict disability in older population. The SPPB is mainly a measure of lower-extremity function and consists of three subtests; 1) Static balance: Standing balance is tested with the feet in the side-by-side, semi tandem and tandem positions for 10 s each; 2) Gait speed: a 4 meter (13ft) walk at the individual´s habitual pace.; 3) Lower limb strength as indicated by the ability to rise from a chair with folded arms across their chest. Baseline, 3 months and 6 months
Secondary Self-efficacy and social support The Self-Efficacy/Social Support scales for Activity for persons with Intellectual Disability (SE/SS-AID) is a questionnaire consisting of four scales, where one scale measure self-efficacy for overcoming barriers to leisure PA. The last three scales measure social support for leisure activity from family members, residential staff, and friends with ID. The scale is validated for self-reporting from individuals with mild to moderate intellectual disability or can be used by proxy respondents. The questionnaire will be translated into the Norwegian language using standard guidelines. Baseline, 3 months and 6 months
Secondary Challenging behaviour The Aberrant Behavior Checklist-Community (ABC-C) is a questionnaire designed to assess challenging behavior in children, youths and adults with an intellectual disability. The ABC is a 58-item checklist grouped into five subscales. It is a proxy measure requiring knowledge of the index person. Assigned weighted scores 0-3 (3 indicating most severe), grouped into five symptom-clusters (irritability, lethargy, stereotypy, hyperactivity, and inappropriate speech). The questionnaire has been validated for use in a Norwegian population with neurodevelopmental disabilities. Baseline, 3 months and 6 months
Secondary Satisfaction with life Satisfaction of life is a scale developed by Bergström, Hochwälder, Kottorp, and Elinder (2013) for assessing satisfaction with home environment and leisure time among individuals with mild to moderate ID. The outcome is measured by four factors: 1) satisfaction with housing environment; 2) satisfaction with life; 3) satisfaction with meals; and 4) satisfaction with recreational activities. Items are read out load by a researcher and answered by 'good' (happy face = 2), 'in between' (neutral face = 1) and 'bad' (sad face = 0). In the current study the scale is used to control for adverse effects. Baseline, 3 months and 6 months
Secondary Social network The Social Support scales for Activity for persons with Intellectual Disability (SS-AID) is a 17-item scale for measuring social support from family, paid staff and roommates with disabilities. The scale is self-report and validated for individuals with mild to moderate intellectual disability. Baseline, 3 months and 6 months
Secondary Goalsetting The Goal attainment scale (GAS) will be used to identify self-management goals that participants want to achieve. The questionnaire will be filled out by the researcher, with participants and proxy respondents present. Completing the GAS involves several steps. Goals are selected by each individual and observable behavior that reflects a degree of goal attainment is defined. The participant's pre-treatment or baseline levels is defined in respect to the goal. Five different goal attainment levels are defined, ranging from "no change" to "much better than expected outcome" (numbered -2 to +2). Follow-up times for participant evaluation are set (presumably after 3- and 6 months). Participants are evaluated after the defined time interval. At the end, the overall attainment score for all goals are calculated. In this study we will define up to three goals for PA. Baseline, 3 months and 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Completed NCT04020302 - Self-Monitoring Shopping Intervention N/A
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT03722212 - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test N/A
Not yet recruiting NCT03644797 - Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs
Completed NCT03139760 - POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability N/A
Not yet recruiting NCT02881333 - Various Type of Genetic Events in Patients With Intellectual Disability N/A
Completed NCT02746614 - Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability N/A
Completed NCT06097819 - Therapy-Based Games' Effects on Motor and Cognitive Skills in Intellectual Disabilities N/A
Recruiting NCT05767203 - Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin N/A
Terminated NCT05445596 - Improving Treatment for Children With Intellectual and Developmental Disabilities and Problem Behavior in Schools N/A
Recruiting NCT05131425 - Facing Your Fears: Adolescents With ASD and Intellectual Disability N/A
Completed NCT04436692 - Dietary Intervention and Adults With Intellectual Disabilities N/A
Completed NCT04917666 - Process and Outcomes of Horticultural Therapy for People With Disabilities N/A
Completed NCT04518358 - Expert Guiding Technology to Help Individuals With Developmental Challenges Build Life and Vocational Skills N/A
Completed NCT04554355 - Effects of a PA Intervention for Fatness and Fitness in Adolescents With Intellectual Disability N/A
Completed NCT04277130 - Effectiveness of Active Video Games in Children With Intellectual Disabilities N/A
Enrolling by invitation NCT02914951 - Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability N/A
Completed NCT03989388 - Occupational Self-Analysis Programme N/A
Completed NCT02591446 - Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders N/A